We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The risk of intrauterine exposure to SARS‐CoV‐2 in female COVID‐19 patients: A comprehensive review.
- Authors
Zhu, Guo‐hua; Liu, Lu; Huang, Xi‐xi; Li, Da‐jin; Zhu, Yi‐zhun; Lu, Xin; Du, Mei‐rong
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new type of coronavirus that has caused fatal infectious diseases and global spread. This novel coronavirus attacks target cells through the interaction of spike protein and angiotensin‐converting enzyme II (ACE2), leading to different clinical symptoms. However, for a successful pregnancy, a well‐established in‐uterine environment includes a specific immune environment, and multi‐interactions between specific cell types are prerequisites. The immune‐related changes in patients infected with novel coronavirus could interfere with the immune microenvironment in the uterus, leading to fetal loss. We first reviewed the intrauterine environment in the normal development process and the possible pregnancy outcome in the infection state. Then, we summarized the immune response induced by SARS‐CoV‐2 in patients and analyzed the changes in ACE2 expression in the female reproductive system. Finally, the present observational evidence of infection in pregnant women was also reviewed.
- Subjects
SARS-CoV-2; COVID-19; CORONAVIRUS diseases; ANGIOTENSIN converting enzyme; WOMEN patients; RISK exposure
- Publication
American Journal of Reproductive Immunology, 2023, Vol 89, Issue 6, p1
- ISSN
1046-7408
- Publication type
Article
- DOI
10.1111/aji.13528